News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InVasc Therapeutics In-Licenses BioLink Patent Application for Alpha Lipoic Acid Salt for Use in Chronic Kidney Disease



5/3/2011 11:27:45 AM

ATLANTA--(BUSINESS WIRE)--InVasc Therapeutics, Inc., a biopharmaceutical company focused on chronic kidney and cardiometabolic diseases, announced today the execution of an in-license agreement for a patent application related to a salt of an alpha lipoic acid derivative from BioLink Life Sciences, Inc. InVasc is developing a drug with alpha lipoic acid in combination with an antihypertensive for the treatment of chronic kidney disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES